Protara Therapeutics, Inc.

NASDAQ:TARA

5.17 (USD) • At close December 24, 2024
Bedrijfsnaam Protara Therapeutics, Inc.
Symbool TARA
Munteenheid USD
Prijs 5.17
Beurswaarde 177,433,366
Dividendpercentage 0%
52-weken bereik 1.595 - 10.48
Industrie Biotechnology
Sector Healthcare
CEO Mr. Jesse Shefferman
Website https://www.protaratx.com

An error occurred while fetching data.

Over Protara Therapeutics, Inc.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement

Vergelijkbare Aandelen

Psychemedics Corporation logo

Psychemedics Corporation

PMD

2.67 USD

Regulus Therapeutics Inc. logo

Regulus Therapeutics Inc.

RGLS

1.54 USD

Microbot Medical Inc. logo

Microbot Medical Inc.

MBOT

0.997 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

11.34 USD

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

1.55 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)